With 0.41 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.51 million shares. The 52-week range on MRTN shows that it touched its highest point at $19.26 and its lowest point at $12.52 during that stretch. It currently has a 1-year price target of $15.50. With its current market cap of 1.06 billion, MRTN has annualized dividend of $0.24 while the current yield stands at 1.84%. Beta for the stock currently stands at 1.00.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MRTN was down-trending over the past week, with a drop of -0.91%, but this was up by 2.60% over a month. Three-month performance dropped to -9.77% while six-month performance fell -25.68%. The stock lost -27.18% in the past year, while it has lost -16.59% so far this year. A look at the trailing 12-month EPS for MRTN yields 0.27 with Next year EPS estimates of 0.52. For the next quarter, that number is 0.08. This implies an EPS growth rate of -3.30% for this year and 62.47% for next year.
Float and Shares Shorts:
At present, 81.46 million MRTN shares are outstanding with a float of 57.45 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for MRTN since 2 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.32352 being high and $0.31944 being low. For MRTN, this leads to a yearly average estimate of $0.32141. Based on analyst estimates, the high estimate for the next quarter is $0.11 and the low estimate is $0.07. The average estimate for the next quarter is thus $0.09.
